Perrigo Company plc Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your Rights – PRGO GlobeNewswire January 06, 2026 NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Perrigo Company plc (“Perrigo Company plc” or the “Company”) (NYSE: PRGO) […]

Levi & Korsinsky Notifies Shareholders of Telix Pharmaceuticals Ltd. (TLX) of a Class Action Lawsuit and an Upcoming Deadline GlobeNewswire January 06, 2026 NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Telix Pharmaceuticals Ltd. (“Telix Pharmaceuticals Ltd.” or the “Company”) (NASDAQ: TLX) of a class action securities lawsuit.

Integer Holdings Corporation Class Action: Levi & Korsinsky Reminds Integer Holdings Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 9, 2026 – ITGR GlobeNewswire January 06, 2026 NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Integer Holdings Corporation (“Integer Holdings Corporation”

Class Action Filed Against Stride, Inc. (LRN) Seeking Recovery for Investors – Contact Levi & Korsinsky GlobeNewswire January 06, 2026 NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to

Shareholders of Freeport-McMoRan Inc. Should Contact Levi & Korsinsky Before January 12, 2026 to Discuss Your Rights – FCX GlobeNewswire January 06, 2026 NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Freeport-McMoRan Inc. (“Freeport-McMoRan Inc.” or the “Company”) (NYSE: FCX) of a class action securities lawsuit. CLASS DEFINITION:

Levi & Korsinsky Notifies Skye Bioscience, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – SKYE GlobeNewswire January 06, 2026 NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Skye Bioscience, Inc. (“Skye Bioscience, Inc.” or the “Company”) (NASDAQ: SKYE) of a class action securities lawsuit. CLASS

(NYSE:KLAR), ATLANTA, Jan. 06, 2026 (GLOBE NEWSWIRE) — A shareholder class action lawsuit has been filed against Klarna Group plc (“Klarna” or the “Company”) (NYSE: KLAR). The lawsuit alleges that Defendants: (1) materially understated the risk that loss reserves would materially go up within a few months of the initial public offering (“IPO”), which they

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Klarna Group plc (KLAR) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm GlobeNewswire January 06, 2026 ATLANTA, Jan. 06, 2026 (GLOBE NEWSWIRE) — A shareholder class action lawsuit has been filed against Klarna Group plc (“Klarna” or the “Company”)

Toll Brothers Announces Final Opportunity to Own a Luxury Home at Fontaine by Toll Brothers in Lake Mary, Florida GlobeNewswire January 06, 2026 Only one home remains in this exclusive gated community in a serene setting LAKE MARY, Fla., Jan. 06, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury

(NasdaqGM:SKYE), NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025, both dates inclusive (the “Class Period”), of the important January 16, 2026 lead plaintiff deadline. SO WHAT: If